Literature DB >> 19389109

Penetrance and clinical consequences of a gross SDHB deletion in a large family.

D C Solis1, N Burnichon, H J L M Timmers, M J Raygada, A Kozupa, M J Merino, D Makey, K T Adams, A Venisse, A-P Gimenez-Roqueplo, K Pacak.   

Abstract

Mutations in the gene encoding subunit B of the mitochondrial enzyme succinate dehydrogenase (SDHB) are inherited in an autosomal dominant manner and are associated with hereditary paraganglioma (PGL) and pheochromocytoma. The phenotype of patients with SDHB point mutations has been previously described. However, the phenotype and penetrance of gross SDHB deletions have not been well characterized as they are rarely described. The objective was to describe the phenotype and estimate the penetrance of an exon 1 large SDHB deletion in one kindred. A retrospective and prospective study of 41 relatives across five generations was carried out. The main outcome measures were genetic testing, clinical presentations, plasma catecholamines and their O-methylated metabolites. Of the 41 mutation carriers identified, 11 were diagnosed with PGL, 12 were found to be healthy carriers after evaluation, and 18 were reportedly healthy based on family history accounts. The penetrance of PGL related to the exon 1 large SDHB deletion in this family was estimated to be 35% by age 40. Variable expressivity of the phenotype associated with a large exon 1 SDHB deletion was observed, including low penetrance, diverse primary PGL tumor locations, and malignant potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389109      PMCID: PMC4718153          DOI: 10.1111/j.1399-0004.2009.01157.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  23 in total

Review 1.  The detection of large deletions or duplications in genomic DNA.

Authors:  J A L Armour; D E Barton; D J Cockburn; G R Taylor
Journal:  Hum Mutat       Date:  2002-11       Impact factor: 4.878

2.  Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.

Authors:  Henri J L M Timmers; Anna Kozupa; Graeme Eisenhofer; Margarita Raygada; Karen T Adams; Daniel Solis; Jacques W M Lenders; Karel Pacak
Journal:  J Clin Endocrinol Metab       Date:  2007-01-02       Impact factor: 5.958

3.  Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?

Authors:  Alberto Cascón; Cristina Montero-Conde; Sergio Ruiz-Llorente; Fátima Mercadillo; Rocío Letón; Cristina Rodríguez-Antona; Beatriz Martínez-Delgado; Manuel Delgado; Alberto Díez; Adela Rovira; José Angel Díaz; Mercedes Robledo
Journal:  Genes Chromosomes Cancer       Date:  2006-03       Impact factor: 5.006

4.  Genetic testing in pheochromocytoma or functional paraganglioma.

Authors:  Laurence Amar; Jérôme Bertherat; Eric Baudin; Christiane Ajzenberg; Brigitte Bressac-de Paillerets; Olivier Chabre; Bernard Chamontin; Brigitte Delemer; Sophie Giraud; Arnaud Murat; Patricia Niccoli-Sire; Stéphane Richard; Vincent Rohmer; Jean-Louis Sadoul; Laurence Strompf; Martin Schlumberger; Xavier Bertagna; Pierre-François Plouin; Xavier Jeunemaitre; Anne-Paule Gimenez-Roqueplo
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

5.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Authors:  Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

6.  Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.

Authors:  Diana E Benn; Michael S Croxson; Kathy Tucker; Christopher P Bambach; Anne Louise Richardson; Leigh Delbridge; Peter T Pullan; Jeremy Hammond; Deborah J Marsh; Bruce G Robinson
Journal:  Oncogene       Date:  2003-03-06       Impact factor: 9.867

7.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

8.  Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.

Authors:  Umasuthan Srirangalingam; Lisa Walker; Bernard Khoo; Fiona MacDonald; Daphne Gardner; Terence J Wilkin; Robert H Skelly; Emad George; David Spooner; John P Monson; Ashley B Grossman; Scott A Akker; Patrick J Pollard; Nick Plowman; Norbert Avril; Daniel M Berney; Jacky M Burrin; Rodney H Reznek; V K Ajith Kumar; Eamonn R Maher; Shern L Chew
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-14       Impact factor: 3.478

9.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

10.  Molecular characterisation of a common SDHB deletion in paraganglioma patients.

Authors:  A Cascón; I Landa; E López-Jiménez; A Díez-Hernández; M Buchta; C Montero-Conde; S Leskelä; L J Leandro-García; R Letón; C Rodríguez-Antona; C Eng; H P H Neumann; M Robledo
Journal:  J Med Genet       Date:  2007-12-05       Impact factor: 6.318

View more
  22 in total

1.  SDHB large deletions are associated with absence of MIBG uptake in metastatic lesions of malignant paragangliomas.

Authors:  Janaina Petenuci; Gustavo F C Fagundes; Anna Flavia F Benedetti; Augusto G Guimaraes; Ana Caroline F Afonso; Flavia T Mota; Aurea Luiza F Magalhães; George B Coura-Filho; Maria Claudia N Zerbini; Sheila Siqueira; Fabio L M Montenegro; Victor Srougi; Fabio Y Tanno; Jose Luis Chambo; Marcela S S Ferrari; Joao Evangelista Bezerra Neto; Maria Adelaide A Pereira; Ana Claudia Latronico; Maria Candida B V Fragoso; Berenice B Mendonca; Ana O Hoff; Madson Q Almeida
Journal:  Endocrine       Date:  2021-01-09       Impact factor: 3.633

2.  Familiar Papillary Thyroid Carcinoma in a Large Brazilian Family Is Not Associated with Succinate Dehydrogenase Defects.

Authors:  Elen Dias Accordi; Paraskevi Xekouki; Bruna Azevedo; Rodrigo Bertollo de Alexandre; Carla Frasson; Siliane Marie Gantzel; Georgios Z Papadakis; Anna Angelousi; Constantine A Stratakis; Vanessa Santos Sotomaior; Fabio R Faucz
Journal:  Eur Thyroid J       Date:  2016-03-10

3.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

4.  A novel mutation of the succinate dehydrogenase B gene in a Korean family with pheochromocytoma.

Authors:  Sang Ah Lee; Eun Hee Kim; Yu Mi Lee; Woochang Lee; Won Ki Min; Young-Joo Lee; Joo Ryung Huh; Woo Je Lee
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

Review 5.  New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.

Authors:  Joakim Crona; David Taïeb; Karel Pacak
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

6.  SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.

Authors:  Ivana Jochmanova; Katherine I Wolf; Kathryn S King; Joan Nambuba; Robert Wesley; Victoria Martucci; Margarita Raygada; Karen T Adams; Tamara Prodanov; Antonio Tito Fojo; Ivica Lazurova; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-03       Impact factor: 4.553

7.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

8.  Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.

Authors:  Maya B Lodish; Karen T Adams; Thanh T Huynh; Tamara Prodanov; Alex Ling; Clara Chen; Suzanne Shusterman; Camilo Jimenez; Maria Merino; Marybeth Hughes; Kendall W Cradic; Dragana Milosevic; Ravinder J Singh; Constantine A Stratakis; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2010-06-03       Impact factor: 5.678

9.  Clinical characteristics and outcomes of SDHB-related pheochromocytoma and paraganglioma in children and adolescents.

Authors:  Ivana Jochmanova; April Melody T Abcede; Ruby Jane S Guerrero; Chandy Lou P Malong; Robert Wesley; Thanh Huynh; Melissa K Gonzales; Katherine I Wolf; Abhishek Jha; Marianne Knue; Tamara Prodanov; Naris Nilubol; Leilani B Mercado-Asis; Constantine A Stratakis; Karel Pacak
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-15       Impact factor: 4.553

10.  Low penetrance of a SDHB mutation in a large Dutch paraganglioma family.

Authors:  Frederik J Hes; Marjan M Weiss; Sanne A Woortman; Noel F de Miranda; Patrick A van Bunderen; Bert A Bonsing; Marcel P M Stokkel; Hans Morreau; Johannes A Romijn; Jeroen C Jansen; Annette H J T Vriends; Jean-Pierre L Bayley; Eleonora P M Corssmit
Journal:  BMC Med Genet       Date:  2010-06-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.